Announcements Trials
Browse Landscape

Status

Recruiting 2Completed 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 22Observational 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 2Advanced Breast Cancer 1

Interventions

Surveys and Questionnaires 18Blood Specimen Collection 16Specimen Handling 12Observation 6Magnetic Resonance Spectroscopy 6Surgical Procedures, Operative 5Radiotherapy 5trastuzumab deruxtecan 4ribociclib 4darolutamide 4Standard of Care 4Patient Reported Outcome Measures 4Letrozole 4Data Collection 4Cryosurgery 4Breath Tests 4Tomography, X-Ray Computed 3Radiation 3Neoadjuvant Therapy 3Magnetic Resonance Imaging 3Biopsy 3Anastrozole 3lorlatinib 2cemiplimab 2atezolizumab 2Ultrasonography 2Trastuzumab 2Staining and Labeling 2Restraint, Physical 2Positron-Emission Tomography 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Anastrozole × 30 days × Clear all
NCT06930859 2026-05-22

ELEGANCE

Novartis

Recruiting
2,766 enrolled
Breast

Breast Neoplasms

NCT07225790 2026-05-12

Emulation of the MONARCH-3 Trial Using Specialty Oncology Electronic Health Records Databases

Brigham and Women's Hospital

Completed
3,883 enrolled
Breast

Advanced Breast Cancer

NCT06905301 2026-05-05

IMPULSE

Novartis

Recruiting
240 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡